Artwork

Innhold levert av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Ep72: Investing in the Future of Digital Therapeutics: Opportunities and Challenges in the Market

37:25
 
Del
 

Manage episode 373589728 series 2857558
Innhold levert av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episoder

Artwork
iconDel
 
Manage episode 373589728 series 2857558
Innhold levert av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episoder

Semua episod

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett